Neuropharmacological profile of 1-azaphenothiazine-10-thiolcarboxylates.
D000311:Adrenal Glands / Q000187:drug effects; D000818:Animals; D000959:Antihypertensive Agents; D001259:Ataxia / Q000139:chemically induced; D002415:Cats; D003864:Depression, Chemical; D004285:Dogs; D004347:Drug Interactions; D000882:Haplorhini; D006591:Hexobarbital / Q000494:pharmacology; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D010640:Phenothiazines / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D012119:Respiration / Q000187:drug effects; D014110:Touch / Q000187:drug effects; D014828:Vocalization, Animal
D000959:Antihypertensive Agents; D010640:Phenothiazines; D006591:Hexobarbital; D010433:Pentylenetetrazole; D009638:Norepinephrine